Approvals/CIMA-AEMPS/BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Menarini International Operations Luxembourg S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 4a5d05c5e564d3c0
Drug Cima Aemps Name: BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: BE390564IP
Holder Company Name: Menarini International Operations Luxembourg S.A.
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/menarini-international-operations-luxembourg-s-a
Authorization Date: 2024-11-15
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/5mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Menarini International Operations Luxembourg S.A.
Company Detail Path: /organization/menarini-international-operations-luxembourg-s-a

OLMESARTAN MEDOXOMILO

40,000 mg

AMLODIPINO BESILATO

6,944 mg

HIDROCLOROTIAZIDA

12,500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 15, 2024

Approval ID

4a5d05c5e564d3c0

Type

Standard